Autism-linked microexon splicing reveals systemic gaps in neurogenetic equity and diagnostic colonialism
Original framing: “A microexon regulatory code reveals autism-linked genetic variation” — Nature
Marginalized voices, such as those of autistic adults from racialized communities or low-income backgrounds, are absent from this study’s framing, despite their critical insights into diagnostic biases and treatment needs. For example, autistic advocates in the Global South often describe how Western genetic research fails to account for local environmental factors (e.g., malnutrition, pollution) that interact with genetic predispositions. The study also ignores the experiences of neurodivergent individuals in non-Western cultures who may not seek biomedical diagnoses due to stigma or lack of access, further marginalizing their perspectives in global research agendas.
This study’s focus on microexon splicing as a sole explanatory factor for autism risks reinforcing a colonial legacy of reducing complex human experiences to genetic codes, while obscuring the systemic inequities that shape who gets studied, diagnosed, and treated.
The absence of Indigenous knowledge systems—such as the Māori *whakapapa* or Navajo *hózhǫ́*—exposes how Western science often erases alternative understandings of neurodivergence, particularly those that view cognitive differences as culturally or spiritually significant rather than pathological. Historical patterns like eugenics-era misdiagnoses and contemporary patenting trends reveal how genetic research can be co-opted to justify exclusionary practices, unless actively decolonized through Indigenous data sovereignty and equitable access models. The trickster figure Coyote might ask: *If we treat autism as a genetic 'glitch,' who benefits from fixing it—and who gets left behind?* The solution lies not just in scientific rigor but in systemic change: integrating marginalized voices, expanding research beyond genetics to environmental and social determinants, and ensuring that advancements in neurogenetics serve global equity rather than corporate or colonial agendas.